You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ETON Sale Disclosure
Krempa David · SEC Form 4 · Filed Aug 24, 2026
Sale
Calculated transaction value
$1.63M
Krempa David Chief Business Officer
ETON
Eton Pharmaceutcials
ETON
Transaction date
Aug 24, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed same day
ETON daily price context
Close on/before transaction
$64.43
Aug 24, 2026
First close after public filing
$63.05
Aug 25, 2026
30-day return after filing
-11.8%
Through Sep 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 25,000 shares @ $65.07
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-028846
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.81M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Eton Pharmaceuticals, Inc. ETON | Exercise | Aug 24, 2026 | $182.75K |
| Eton Pharmaceuticals, Inc. ETON Current | Sale | Aug 24, 2026 | $1.63M |
| Eton Pharmaceuticals, Inc. ETON | Exercise | Aug 24, 2026 | $0 |